3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
2
Melanoma
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Skin Neoplasms
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Glioma
1
Colorectal Neoplasms
1
Breast Neoplasms, Male
1
Brain Neoplasms
1
Interventions
Sorafenib
23
Bevacizumab
11
Radiosurgery
6
Capecitabine
6
Radiofrequency Ablation
5
Oxaliplatin
5
Fluorouracil
5
Doxorubicin
5
pembrolizumab
4
Sunitinib
4
Erlotinib Hydrochloride
4
Cisplatin
4
Ramucirumab
3
Radiotherapy
3
Nivolumab
3
Leucovorin
3
Carboplatin
3
tremelimumab
2
spartalizumab
2
perflutren
2
derazantinib
2
carotuximab
2
Mitomycin
2
Magnetic Resonance Spectroscopy
2
Magnetic Resonance Imaging
2
Ipilimumab
2
Immunohistochemistry
2
Gemcitabine
2
Folfox protocol
2
Fluorodeoxyglucose F18
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Liver Neoplasms
×
Antibodies, Monoclonal
×
Clear all
No trials found.